|
|
| March 9, 2013: Dr. Jane Margaret Armitage and Dr. C. Michael Gibson discuss: HPS2-THRIVE: Randomized Comparison Of Extended-Release (ER |
Dr. Jane Margaret Armitage and Dr. C. Michael Gibson discuss: HPS2-THRIVE: Randomized
Comparison Of Extended-Release (ER) niacin/laropiprant 2g Daily Versus Placebo in 25,673
Patients At High Risk Of Occlusive Vascular Events
Grant to Oxford University. Designed, conducted and analysed independently of the grant
source (Merck & Co). No honoraria or consultancy fees accepted.
[ Download video ] |
|
No comments have been submitted
|